{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T09:00:06Z","timestamp":1785056406338,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","award":["ANSM 2015-A01747-42"],"award-info":[{"award-number":["ANSM 2015-A01747-42"]}],"id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute lung injury (ALI) after extracorporeal circulation can originate from multiple causes, including transfusion. Despite improvements in blood safety policy, transfusion-related lung injury (TRALI) continues to occur, suggesting an incomplete understanding of its pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To evaluate the association between the composition of the red blood cell unit (RBC) and the onset of ALI after transfusion, defined by a ratio between partial pressure of oxygen (PaO\n                      <jats:sub>2<\/jats:sub>\n                      ) and the fraction of inspired oxygen (FiO\n                      <jats:sub>2<\/jats:sub>\n                      )\u2009\u2264\u2009300\u00a0mmHg in the first 3\u00a0days postoperatively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults undergoing scheduled cardiac surgery at Nantes University Hospital between September 2016 and March 2021 and requiring transfusion of 1\u20135 RBC during surgery were included. To determine the exposure of each patient (i.e., total amount of inflammatory proteins received during transfusion), we analyzed the composition (panel of 15 proteins) of each RBC received by the participants. After stimulation of peripheral blood mononuclear cells (PBMC) with supernatant RBC (SN-RBC), NK cell cytotoxicity to pulmonary epithelial cells (Calu_3 cells) was assessed. Finally, we determined the association between SN-RBC composition, patient characteristics, and blood donation preparation methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over the study period, 161 patients were included, of whom 54 (33.5%) developed ALI within the first 3\u00a0days. Patients with ALI had a significantly higher median (IQR) exposure to SDF_1\u03b1 than non-ALI patients 2.0\u2009\u00d7\u200910\n                      <jats:sup>4<\/jats:sup>\n                      (0.0 to 4.2\u2009\u00d7\u200910\n                      <jats:sup>4<\/jats:sup>\n                      ) vs. 1.0\u2009\u00d7\u200910\n                      <jats:sup>4<\/jats:sup>\n                      (0.0 to 2.7\u2009\u00d7\u200910\n                      <jats:sup>4<\/jats:sup>\n                      ) picograms,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02. In vitro, PBMC coculture with SN-RBC containing high levels of SDF_1\u03b1 enhanced NKG2D-dependant NKG2A\n                      <jats:sup>+<\/jats:sup>\n                      NK cell cytotoxicity to Calu_3 cells. RBC from female donors or donors with platelet counts higher than 300\u2009\u00d7\u200910\n                      <jats:sup>9<\/jats:sup>\n                      \/L showed the highest concentration of SDF_1\u03b1, as well as RBC prepared by \"whole blood filtration\".\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      High exposure to SDF_1\u03b1 through transfusion may be associated with the onset of ALI following cardiac surgery. The increase in NKG2D-dependent cytotoxicity of NKG2A\n                      <jats:sup>+<\/jats:sup>\n                      NK cells is a possible explanation for this finding. These results advocate for better characterization of the determinants of RBC composition and for developing new immune strategies to mitigate transfusion side effects.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-026-00919-z","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:48:59Z","timestamp":1784778539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of SDF_1\u03b1\/CXCR4 axis in non-antibody mediated TRALI in cardiac surgery patients"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-7728","authenticated-orcid":false,"given":"Mickael","family":"Vourc\u2019h","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enora","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Volteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Poschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Braud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"Josien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Rozec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A","family":"Villadangos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Retiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Asehnoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"919_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jtcvs.2019.04.039","volume":"159","author":"D Vervoort","year":"2020","unstructured":"Vervoort D, Meuris B, Meyns B, Verbrugghe P (2020) Global cardiac surgery: access to cardiac surgical care around the world. J Thorac Cardiovasc Surg 159:987-996.e6. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.04.039","journal-title":"J Thorac Cardiovasc Surg"},{"key":"919_CR2","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.21037\/jtd-20-2213","volume":"13","author":"PG Chan","year":"2021","unstructured":"Chan PG, Seese L, Aranda-Michel E et al (2021) Operative mortality in adult cardiac surgery: is the currently utilized definition justified? J Thorac Dis 13:5582\u20135591. https:\/\/doi.org\/10.21037\/jtd-20-2213","journal-title":"J Thorac Dis"},{"key":"919_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ihj.2019.07.004","volume":"71","author":"C Patra","year":"2019","unstructured":"Patra C, Gatti PC, Panigrahi A (2019) Morbidity after cardiac surgery under cardiopulmonary bypass and associated factors: a retrospective observational study. Indian Heart J 71:350\u2013355. https:\/\/doi.org\/10.1016\/j.ihj.2019.07.004","journal-title":"Indian Heart J"},{"key":"919_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.jvca.2011.11.007","volume":"26","author":"M Garc\u00eda-Delgado","year":"2012","unstructured":"Garc\u00eda-Delgado M, Navarrete I, Garc\u00eda-Palma MJ, Colmenero M (2012) Postoperative respiratory failure after cardiac surgery: use of noninvasive ventilation. J Cardiothorac Vasc Anesth 26:443\u2013447. https:\/\/doi.org\/10.1053\/j.jvca.2011.11.007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"919_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1378\/chest.07-1028","volume":"133","author":"F Filsoufi","year":"2008","unstructured":"Filsoufi F, Rahmanian PB, Castillo JG et al (2008) Predictors and early and late outcomes of respiratory failure in contemporary cardiac surgery. Chest 133:713\u2013721. https:\/\/doi.org\/10.1378\/chest.07-1028","journal-title":"Chest"},{"key":"919_CR6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.athoracsur.2011.04.019","volume":"92","author":"ML Bailey","year":"2011","unstructured":"Bailey ML, Richter SM, Mullany DV et al (2011) Risk factors and survival in patients with respiratory failure after cardiac operations. Ann Thorac Surg 92:1573\u20131579. https:\/\/doi.org\/10.1016\/j.athoracsur.2011.04.019","journal-title":"Ann Thorac Surg"},{"key":"919_CR7","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1378\/chest.119.3.884","volume":"119","author":"J Milot","year":"2001","unstructured":"Milot J, Perron J, Lacasse Y et al (2001) Incidence and predictors of ARDS after cardiac surgery. Chest 119:884\u2013888. https:\/\/doi.org\/10.1378\/chest.119.3.884","journal-title":"Chest"},{"key":"919_CR8","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1378\/chest.102.5.1313","volume":"102","author":"JP Wiener-Kronish","year":"1992","unstructured":"Wiener-Kronish JP (1992) Postoperative pleural and pulmonary abnormalities in patients undergoing coronary artery bypass grafts. Chest 102:1313\u20131314. https:\/\/doi.org\/10.1378\/chest.102.5.1313","journal-title":"Chest"},{"issue":"Suppl 1","key":"919_CR9","doi-asserted-by":"publisher","first-page":"i29","DOI":"10.1093\/bja\/aes422","volume":"109","author":"K Karkouti","year":"2012","unstructured":"Karkouti K (2012) Transfusion and risk of acute kidney injury in cardiac surgery. Br J Anaesth 109(Suppl 1):i29\u2013i38. https:\/\/doi.org\/10.1093\/bja\/aes422","journal-title":"Br J Anaesth"},{"key":"919_CR10","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/circulationaha.107.698977","volume":"116","author":"GJ Murphy","year":"2007","unstructured":"Murphy GJ, Reeves BC, Rogers CA et al (2007) Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116:2544\u20132552. https:\/\/doi.org\/10.1161\/circulationaha.107.698977","journal-title":"Circulation"},{"key":"919_CR11","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/jep.13334","volume":"26","author":"J Thanavaro","year":"2020","unstructured":"Thanavaro J, Taylor J, Vitt L et al (2020) Predictors and outcomes of postoperative respiratory failure after cardiac surgery. J Eval Clin Pract 26:1490\u20131497. https:\/\/doi.org\/10.1111\/jep.13334","journal-title":"J Eval Clin Pract"},{"key":"919_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.aat.2012.08.005","volume":"50","author":"H-I Tsai","year":"2012","unstructured":"Tsai H-I, Chou A-H, Yang M-W (2012) Perioperative transfusion-related acute lung injury: a retrospective analysis. Acta Anaesthesiol Taiwan 50:96\u2013100. https:\/\/doi.org\/10.1016\/j.aat.2012.08.005","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"919_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/aia.0000000000000178","volume":"56","author":"GR Lorello","year":"2018","unstructured":"Lorello GR, Alam A (2018) Perioperative transfusion-related acute lung injury. Int Anesthesiol Clin 56:47\u201367. https:\/\/doi.org\/10.1097\/aia.0000000000000178","journal-title":"Int Anesthesiol Clin"},{"key":"919_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1175387","volume":"14","author":"Y Yu","year":"2023","unstructured":"Yu Y, Lian Z (2023) Update on transfusion-related acute lung injury: an overview of its pathogenesis and management. Front Immunol 14:1175387. https:\/\/doi.org\/10.3389\/fimmu.2023.1175387","journal-title":"Front Immunol"},{"key":"919_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953195","volume":"13","author":"D Scozzi","year":"2022","unstructured":"Scozzi D, Liao F, Krupnick AS et al (2022) The role of neutrophil extracellular traps in acute lung injury. Front Immunol 13:953195. https:\/\/doi.org\/10.3389\/fimmu.2022.953195","journal-title":"Front Immunol"},{"key":"919_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.639976","volume":"8","author":"K Guo","year":"2021","unstructured":"Guo K, Ma S (2021) The immune system in transfusion-related acute lung injury prevention and therapy: update and perspective. Front Mol Biosci 8:639976. https:\/\/doi.org\/10.3389\/fmolb.2021.639976","journal-title":"Front Mol Biosci"},{"key":"919_CR17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jacbts.2022.02.019","volume":"7","author":"M Vourc\u2019h","year":"2022","unstructured":"Vourc\u2019h M, Roquilly A, Foucher A et al (2022) Transfusion-related renal dysfunction after cardiac surgery the role of myeloid-related Protein_14 in neutrophil-mediated tubular damage. JACC Basic Transl Sci 7:627\u2013638. https:\/\/doi.org\/10.1016\/j.jacbts.2022.02.019","journal-title":"JACC Basic Transl Sci"},{"key":"919_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1324021","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang R, Song C et al (2023) Crosstalk between neutrophil extracellular traps and immune regulation: insights into pathobiology and therapeutic implications of transfusion-related acute lung injury. Front Immunol 14:1324021. https:\/\/doi.org\/10.3389\/fimmu.2023.1324021","journal-title":"Front Immunol"},{"key":"919_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1182\/blood-2010-05-286146","volume":"117","author":"UJH Sachs","year":"2011","unstructured":"Sachs UJH, Wasel W, Bayat B et al (2011) Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 117:669\u2013677. https:\/\/doi.org\/10.1182\/blood-2010-05-286146","journal-title":"Blood"},{"key":"919_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1164\/rccm.202110-2324oc","volume":"206","author":"T Chaumette","year":"2022","unstructured":"Chaumette T, Cinotti R, Moll\u00e9 A et al (2022) Monocyte signature associated with herpes simplex virus reactivation and neurological recovery after brain injury. Am J Respir Crit Care Med 206:295\u2013310. https:\/\/doi.org\/10.1164\/rccm.202110-2324oc","journal-title":"Am J Respir Crit Care Med"},{"key":"919_CR21","doi-asserted-by":"crossref","unstructured":"Charpentier E, Cornec M, Dumont S, Meistermann M, Bordron P, David L, et al. 3\u2019 RNA sequencing for robust and low-cost gene expression profiling.2021. https:\/\/www.protocols.io\/view\/3-rna-sequencing-for-robust-and-low-cost-gene-expr-n2bvj94ewlk5\/v1. Accessed 29 Sept 2025","DOI":"10.21203\/rs.3.pex-1336\/v1"},{"key":"919_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113229","volume":"11","author":"T Letellier","year":"2022","unstructured":"Letellier T, Kervella D, Sadek A et al (2022) Time-limited therapy with belatacept in kidney transplant recipients. J Clin Med 11:3229. https:\/\/doi.org\/10.3390\/jcm11113229","journal-title":"J Clin Med"},{"key":"919_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci137047","author":"DR Calabrese","year":"2020","unstructured":"Calabrese DR, Aminian E, Mallavia B et al (2020) Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury. J Clin Investig. https:\/\/doi.org\/10.1172\/jci137047","journal-title":"J Clin Investig"},{"key":"919_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.164603","volume":"7","author":"DR Calabrese","year":"2022","unstructured":"Calabrese DR, Tsao T, Magnen M et al (2022) NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes. JCI Insight 7:e164603. https:\/\/doi.org\/10.1172\/jci.insight.164603","journal-title":"JCI Insight"},{"key":"919_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1164\/rccm.202311-2033ed","volume":"209","author":"E Letsiou","year":"2023","unstructured":"Letsiou E, Dudek SM (2023) Natural killer cell ligands: another source of heterogeneity in acute lung injury pathophysiology? Am J Respir Crit Care Med 209:8\u201310. https:\/\/doi.org\/10.1164\/rccm.202311-2033ed","journal-title":"Am J Respir Crit Care Med"},{"key":"919_CR26","doi-asserted-by":"publisher","first-page":"e2832","DOI":"10.1038\/cddis.2016.482","volume":"8","author":"FM Konrad","year":"2017","unstructured":"Konrad FM, Meichssner N, Bury A et al (2017) Inhibition of SDF-1 receptors CXCR4 and CXCR7 attenuates acute pulmonary inflammation via the adenosine A2B-receptor on blood cells. Cell Death Dis 8:e2832\u2013e2832. https:\/\/doi.org\/10.1038\/cddis.2016.482","journal-title":"Cell Death Dis"},{"key":"919_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.951764","volume":"10","author":"C Liu","year":"2022","unstructured":"Liu C, Xiao K, Xie L (2022) Advances in mesenchymal stromal cell therapy for acute lung injury\/acute respiratory distress syndrome. Front Cell Dev Biol 10:951764. https:\/\/doi.org\/10.3389\/fcell.2022.951764","journal-title":"Front Cell Dev Biol"},{"key":"919_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104811","volume":"96","author":"M Lachota","year":"2023","unstructured":"Lachota M, Zielniok K, Palacios D et al (2023) Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation. EBioMedicine 96:104811. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104811","journal-title":"EBioMedicine"},{"key":"919_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35095564","volume":"1","author":"A Cerwenka","year":"2001","unstructured":"Cerwenka A, Lanier LL (2001) Natural killer cells, viruses and cancer. Nat Rev Immunol 1:41\u201349. https:\/\/doi.org\/10.1038\/35095564","journal-title":"Nat Rev Immunol"},{"key":"919_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1164\/rccm.202303-0472oc","volume":"209","author":"OA Aguilar","year":"2024","unstructured":"Aguilar OA, Qualls AE, Gonzalez-Hinojosa MDR et al (2024) MICB genomic variant is associated with NKG2D-mediated acute lung injury and death. Am J Respir Crit Care Med 209:70\u201382. https:\/\/doi.org\/10.1164\/rccm.202303-0472oc","journal-title":"Am J Respir Crit Care Med"},{"key":"919_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fimmu.2018.00441","volume":"9","author":"FM Wensveen","year":"2018","unstructured":"Wensveen FM, Jelen\u010di\u0107 V, Poli\u0107 B (2018) NKG2D: a master regulator of immune cell responsiveness. Front Immunol 9:441. https:\/\/doi.org\/10.3389\/fimmu.2018.00441","journal-title":"Front Immunol"},{"key":"919_CR32","first-page":"2064","volume":"9","author":"H Liu","year":"2019","unstructured":"Liu H, Wang S, Xin J et al (2019) Role of NKG2D and its ligands in cancer immunotherapy. Am J Cancer Res 9:2064\u20132078","journal-title":"Am J Cancer Res"},{"key":"919_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10875-025-01913-y","volume":"45","author":"E Ferron","year":"2025","unstructured":"Ferron E, Jullien M, Braud M et al (2025) Molecular interactions between NK cells and acute leukemic cells: KIR2DL5 drastically limits NK cell responses. J Clin Immunol 45:118. https:\/\/doi.org\/10.1007\/s10875-025-01913-y","journal-title":"J Clin Immunol"},{"key":"919_CR34","doi-asserted-by":"publisher","first-page":"37222","DOI":"10.1074\/jbc.m111.294116","volume":"286","author":"C Delgado-Mart\u00edn","year":"2011","unstructured":"Delgado-Mart\u00edn C, Escribano C, Pablos JL et al (2011) Chemokine CXCL12 uses CXCR4 and a signaling core formed by bifunctional Akt, extracellular signal-regulated kinase (ERK)1\/2, and mammalian target of rapamycin complex 1 (mTORC1) proteins to control chemotaxis and survival simultaneously in mature dendritic cells*. J Biol Chem 286:37222\u201337236. https:\/\/doi.org\/10.1074\/jbc.m111.294116","journal-title":"J Biol Chem"},{"key":"919_CR35","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","volume":"25","author":"L Rebuffet","year":"2024","unstructured":"Rebuffet L, Melsen JE, Escali\u00e8re B et al (2024) High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nat Immunol 25:1474\u20131488. https:\/\/doi.org\/10.1038\/s41590-024-01883-0","journal-title":"Nat Immunol"},{"key":"919_CR36","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1707572","volume":"377","author":"DJ Cooper","year":"2017","unstructured":"Cooper DJ, McQuilten ZK, Nichol A et al (2017) Age of red cells for transfusion and outcomes in critically ill adults. N Engl J Med 377:NEJMoa1707572-1867. https:\/\/doi.org\/10.1056\/nejmoa1707572","journal-title":"N Engl J Med"},{"key":"919_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/cmi.2017.107","volume":"15","author":"R Janssens","year":"2018","unstructured":"Janssens R, Struyf S, Proost P (2018) The unique structural and functional features of CXCL12. Cell Mol Immunol 15:299\u2013311. https:\/\/doi.org\/10.1038\/cmi.2017.107","journal-title":"Cell Mol Immunol"},{"key":"919_CR38","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/circresaha.110.220970","volume":"107","author":"M Cheng","year":"2010","unstructured":"Cheng M, Zhou J, Wu M et al (2010) CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity. Circ Res 107:1083\u20131093. https:\/\/doi.org\/10.1161\/circresaha.110.220970","journal-title":"Circ Res"},{"key":"919_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/icvts\/ivx358","volume":"26","author":"R Tu","year":"2018","unstructured":"Tu R, Peng Y, Wang Y et al (2018) The stromal cell-derived factor 1\/C-X-C chemokine receptor type 4 axis is important in neutrophil migration caused by cardiopulmonary bypass in children. Interact Cardiovasc Thorac Surg 26:431\u2013437. https:\/\/doi.org\/10.1093\/icvts\/ivx358","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"919_CR40","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10753-017-0538-0","volume":"40","author":"H Shi","year":"2017","unstructured":"Shi H, Lu R, Wang S et al (2017) Effects of SDF-1\/CXCR4 on acute lung injury induced by cardiopulmonary bypass. Inflammation 40:937\u2013945. https:\/\/doi.org\/10.1007\/s10753-017-0538-0","journal-title":"Inflammation"},{"key":"919_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/1440-1681.12845","volume":"45","author":"SP Nassoiy","year":"2018","unstructured":"Nassoiy SP, Babu FS, LaPorte HM, Majetschak M (2018) Pharmacological modulation of C-X-C motif chemokine receptor 4 influences development of acute respiratory distress syndrome after lung ischaemia\u2013reperfusion injury. Clin Exp Pharmacol Physiol 45:16\u201326. https:\/\/doi.org\/10.1111\/1440-1681.12845","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"919_CR42","doi-asserted-by":"publisher","first-page":"F783","DOI":"10.1152\/ajprenal.00685.2013","volume":"307","author":"A Zuk","year":"2014","unstructured":"Zuk A, Gershenovich M, Ivanova Y et al (2014) CXCR4 antagonism as a therapeutic approach to prevent acute kidney injury. Am J Physiol Ren Physiol 307:F783\u2013F797. https:\/\/doi.org\/10.1152\/ajprenal.00685.2013","journal-title":"Am J Physiol Ren Physiol"},{"key":"919_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.37609\/srinmed.46","volume":"2","author":"B \u015eahin","year":"2025","unstructured":"\u015eahin B, Jaradat \u00d6, Dolu Z (2025) Delayed presentation of transfusion-related acute lung injury in the emergency department. Sci Rep Med 2:211\u2013215. https:\/\/doi.org\/10.37609\/srinmed.46","journal-title":"Sci Rep Med"},{"key":"919_CR44","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1182\/blood-2008-07-166264","volume":"113","author":"NS Mangalmurti","year":"2009","unstructured":"Mangalmurti NS, Xiong Z, Hulver M et al (2009) Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood 113:1158\u20131166. https:\/\/doi.org\/10.1182\/blood-2008-07-166264","journal-title":"Blood"},{"key":"919_CR45","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/jth.12404","volume":"11","author":"M Chatterjee","year":"2013","unstructured":"Chatterjee M, Gawaz M (2013) Platelet-derived CXCL12 (SDF-1\u03b1): basic mechanisms and clinical implications. J Thromb Haemost 11:1954\u20131967. https:\/\/doi.org\/10.1111\/jth.12404","journal-title":"J Thromb Haemost"},{"key":"919_CR46","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1182\/bloodadvances.2020001658","volume":"4","author":"C Gamonet","year":"2020","unstructured":"Gamonet C, Desmarets M, Mourey G et al (2020) Processing methods and storage duration impact extracellular vesicle counts in red blood cell units. Blood Adv 4:5527\u20135539. https:\/\/doi.org\/10.1182\/bloodadvances.2020001658","journal-title":"Blood Adv"},{"key":"919_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86037-0","volume":"11","author":"D Sanchez-Guzman","year":"2021","unstructured":"Sanchez-Guzman D, Boland S, Brookes O et al (2021) Long-term evolution of the epithelial cell secretome in preclinical 3D models of the human bronchial epithelium. Sci Rep 11:6621. https:\/\/doi.org\/10.1038\/s41598-021-86037-0","journal-title":"Sci Rep"},{"key":"919_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.18502\/ijaai.v18i5.1917","volume":"18","author":"A Mardomi","year":"2019","unstructured":"Mardomi A, Hossein-Nataj H, Jafari N et al (2019) SDF-1\u03b1 Reduces Human Natural Killer Cell Cytotoxicity against Chronic Myelogenous Leukemia K562 Cells. Iran J Allergy Asthma Immunol 18:493\u2013500. https:\/\/doi.org\/10.18502\/ijaai.v18i5.1917","journal-title":"Iran J Allergy Asthma Immunol"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00919-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-026-00919-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00919-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T08:01:03Z","timestamp":1785052863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40635-026-00919-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1186\/s40635-026-00919-z","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was registered at clinicaltrial.gov (NCT02763410) before the first inclusion. The protocol was reviewed by an institutional board and the participants received oral and written information during the preoperative consultation. Patients provided written consent for the storage of biological samples (Ethics Committee Ouest V, Rennes, #16\/02\u20131000, approval March 4, 2016).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain individual person\u2019s data.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Vourc'h reported receiving personal fees from MSD, Pfizer, and Baxter and grants from Fisher & Paykel outside the submitted work. Pr. Roquilly reported receiving grants from the French Ministry of Health during the conduct of the study and personal fees from bioMerieux and MSD outside of the submitted work. Pr. Asehnoune reported receiving personal fees from Baxter, LFB, Edwards Lifesciences, and Fisher & Paykel, outside the submitted work. Pr. Rozec declared having received personal fees from LFB, Aguettant, Nordic Pharma, and i-Sep. The other authors declare that they have no conflicts of interest involving the work under consideration for publication.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"100"}}